During the past decade, H. Lee Moffitt Cancer Center and Research Institute at University of South Florida conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 24 clinical trials were completed, i.e. on average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "H. Lee Moffitt Cancer Center and Research Institute at University of South Florida" #1 sponsor was "Radiation Therapy Oncology Group" with 13 trials, followed by "SWOG Cancer Research Network" with 7 trials sponsored, "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 7 trials sponsored, "Eastern Cooperative Oncology Group" with 4 trials sponsored and "Alliance for Clinical Trials in Oncology" with 4 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "H. Lee Moffitt Cancer Center and Research Institute at University of South Florida" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "H. Lee Moffitt Cancer Center and Research Institute at University of South Florida" are "Brain and Central Nervous System Tumors" (10 trials), "Lymphoma" (10 trials), "Leukemia" (9 trials), "Breast Cancer" (6 trials) and "Head and Neck Cancer" (6 trials). Many other conditions were trialed in "H. Lee Moffitt Cancer Center and Research Institute at University of South Florida" in a lesser frequency.

Most popular intervention types in "H. Lee Moffitt Cancer Center and Research Institute at University of South Florida" are "Drug" (48 trials), "Biological" (24 trials), "Radiation" (20 trials), "Procedure" (15 trials) and "Other" (14 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (9 trials), "cisplatin" (6 trials), "laboratory biomarker analysis" (6 trials), "docetaxel" (5 trials) and "Placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "H. Lee Moffitt Cancer Center and Research Institute at University of South Florida" are 61 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "H. Lee Moffitt Cancer Center and Research Institute at University of South Florida". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, 12 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".